Kassandra Kisler, PhD

Assistant Professor of Research Physiology & Neuroscience

Assistant Director of the Optical Imaging Core and Research Operations for The Center for Neurodegeneration and Regeneration

Image of Kassandra Kisler, PhD
Is this your profile? Click to edit

Overview

Dr. Kisler is the Assistant Director of the Optical Imaging Core at the Center for Neurodegeneration and Regeneration at the Zilkha Neurogenetic Institute. She received her PhD in applied physics from Cornell University where she used a combination of microscopy and electrophysiology techniques to study cell biology. Her interests lie in understanding the contribution of neurovascular dysfunction to dementia and related conditions, and developing therapeutic and preventative treatments for neurodegenerative diseases. She focuses on the application of in vivo imaging techniques to study vascular dynamics and the cells that regulate vascular function in the living brain. Vascular dysfunction and loss of blood-brain barrier (BBB) integrity occurs during Alzheimer’s disease progression and in several other neurological diseases, but the causes and consequences are not well understood. Dr. Kisler’s current work builds upon her experience to tackle important questions related to blood-brain barrier (BBB) integrity, vascular regulation and function, its relation to brain electrical activity, and the mechanisms underlying neurodegenerative diseases such as Alzheimer’s using transgenic model animals and in vitro approaches. In this role, she also investigates the effects of highly validated Alzheimer’s disease risk genes APOE4 and PICALM on neurovascular and brain function using microscopy, traditional biochemical techniques and next-generation omics technologies.

Education and Training

  • Cornell University, Ithaca, NY — PhD — Applied Physics
  • UC Davis, Davis, CA — BAS — Applied Physics, Chemistry

Research Keywords

  • Neurovascular function
  • Blood-brain barrier
  • Alzheimer's disease
  • Stroke
  • Microscopy

Publications

  • Multi-omic profiling reveals pericyte and smooth muscle cell contributions to CADASIL pathology in cell-specific Notch3 mutant mice. Cell Rep. 2026 Apr 16; 45(4):117285.. View in PubMed
  • APOE-Targeted Therapeutics for Alzheimer’s Disease. J Neurosci. 2025 11 12; 45(46).. View in PubMed
  • Brain pericytes derived from human pluripotent stem cells retain vascular and phagocytic functions under hypoxia. Stem Cells. 2025 10 16; 43(11).. View in PubMed
  • Neural xenografts contribute to long-term recovery in stroke via molecular graft-host crosstalk. Nat Commun. 2025 Sep 16; 16(1):8224.. View in PubMed
  • A Bivalent Protease-Activated Receptor-Derived Peptide Mimics Neuronal Anti-Apoptotic Activity of Activated Protein C. Bioengineering (Basel). 2025 Aug 22; 12(9).. View in PubMed
  • The blood-brain barrier: a help and a hindrance. Brain. 2025 Jul 07; 148(7):2262-2282.. View in PubMed
  • Molecular signature and functional properties of human pluripotent stem cell-derived brain pericytes. bioRxiv. 2025 Apr 28.. View in PubMed
  • A molecular brain atlas reveals cellular shifts during the repair phase of stroke. J Neuroinflammation. 2025 Apr 18; 22(1):112.. View in PubMed
  • The blood-brain barrier as a treatment target for neurodegenerative disorders. Expert Opin Drug Deliv. 2025 May; 22(5):673-692.. View in PubMed
  • In vivo neuroprotection in ischemic stroke by activated protein C requires β-arrestin 2. Blood Vessel Thromb Hemost. 2025 Feb; 2(1).. View in PubMed